Information Provided By: 
Fly News Breaks for August 22, 2017
TNDM, DXCM, MDT
Aug 22, 2017 | 10:34 EDT
JPMorgan analyst Michael Weinstein noted that Medtronic (MDT) guided for its diabetes revenues to be down sequentially in the second and third quarters and lowered its diabetes growth guidance for the year. He said Medtronic's challenges "are naturally competitors' gains," and tells investors that he expects Dexcom (DXCM) and Tandem Diabetes (TNDM) to respond favorably to the news. Weinstein has an Overweight rating on Dexcom shares.
News For MDT;DXCM;TNDM From the Last 2 Days
